Metals, oxidative stress, and hepatic fibrogenesis

Seminars in Liver Disease

Volumn 16, Issue 1, 1996, Pages 13-30

  Pietrangelo, Antonello ^a,b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CALMODULIN; CARBON TETRACHLORIDE; COLLAGEN; COPPER; CYTOCHROME P450; CYTOKINE; ENTACTIN; EPIDERMAL GROWTH FACTOR; FIBRONECTIN; GLYCOPROTEIN; GLYCOSAMINOGLYCAN; HYDROGEN PEROXIDE; HYDROXYL RADICAL; INTEGRIN; IRON; LAMININ; MEMBRANE RECEPTOR; METAL; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROCOLLAGEN; PROTEOGLYCAN; REACTIVE OXYGEN METABOLITE; SYNDECAN; TENASCIN; THROMBOSPONDIN; TRANSFORMING GROWTH FACTOR BETA; UNDULIN; UNINDEXED DRUG; VITRONECTIN;

COPPER METABOLISM; EXTRACELLULAR MATRIX; FIBROGENESIS; GENE EXPRESSION; HUMAN; IMMUNOELECTRON MICROSCOPY; IN SITU HYBRIDIZATION; IRON OVERLOAD; KUPFFER CELL; LIPID PEROXIDATION; LIVER FIBROSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; STELLATE CELL;

EID: 0029922315     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007215     Document Type: Review

References (117)

1. Friedman SL: The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 328:1828-35, 1993.
2. Sternlieb I: Copper and zinc. In: Arias IM, Bojer JL, Fausto N, et al (eds) The liver. Biology and pathobiology. New York, Raven Press, 1994, pp 585-96.
3. Weintraub LR, Goral A, Grasso J, et al: Pathogenesis of hepatic fibrosis in experimental iron overload. Br J Haematol 59:321-31, 1985.
4. Bissell DM: Cell-matrix interaction and hepatic fibrosis. Prog Liver Dis 9:143-55, 1990.
5. Schuppan D: Structure of the extracellular matrix in normal and fibrotic liver. Semin Liver Dis 106:145-55, 1992.
6. Rojkind M, Greenwel P: The extracellular matrix of the liver. In: Arias IM, Bojer JL, Fausto N, et al (eds) The liver. Biology and pathobiology. New York, Raven Press, 1994, pp 843-68.
7. Burgeson RE: New collagens, new concepts. Annu Rev Cell Biol 4:551-7, 1988.
8. Prockop DJ, Kivirikko KL: Collagens: molecular biology, diseases, and potential for therapy. Annu Rev Biochem 64:403-34, 1995.
9. Rojkind M, Giambrone M-A, Biempica L: Collagen types in normal and cirrhotic liver. Gastroenterology 76:710-9, 1979.
10. Ruoslahti E: Fibronectin and its receptor. Annu Rev Biochem 57:375-413, 1990.
11. Schwarzbauer JE: Alternative splicing of fibronectin: three variants, three functions. Bioessays 13:527-33, 1991.
12. Humphries MJ, Obara M, Olden K, Yamada KM: Role of fibronectin in adhesion, migration and metastasis. Cancer Invest 7:373-93, 1989.
13. Chiquet-Ehrismann R, Mackie EJ, Pearson CA, et al: Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47:131-9, 1986.
14. Miyazaki H, Van Eyken P, Roskams T, et al: Transient expression of tenascin in experimentally induced cholestatic fibrosis in rat liver: an immunohistochemical study. J Hepatol 19:353-66, 1993.
15. Frazier WA: Thrombospondins. Curr Opin Cell Biol 3:792-9, 1991.
16. Lawler J, Hynes R: The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins. J Cell Biol 103:1635-48, 1986.
17. Just M, Herbst H, Hummel M, et al: Undulin is a novel member of the fibronectin-tenascin gene family of extracellular matrix glycoproteins. J Biol Chem 266:17326-32, 1991.
18. Knittel T, Odenthal M, Schuppan D, et al: Synthesis of undulin by rat liver fat-storing cells: comparison with fibronectin and tenascin. Exp Cell Res 203:312-20, 1992.
19. Timpl R: Structure and biological activity of basement membrane proteins. Eur J Biochem 180:487-502, 1989.
20. Bissell DM, Stamatoglu S, Nermut M, et al: Interaction of rat hepatocytes with type IV collagen, fibronectin and laminin matrices. Eur J Cell Biol 40:72-8, 1986.
21. Ruoslahti E: Structure and biology of proteoglycans. Annu Rev Cell Biol 4:229-55, 1988.
22. Bernfield M, Kokenyesi R, Kato M, et al: Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 8:365-93, 1992.
23. Meyer DH, Krull N, Dreher KL, et al: Biglycan and decorin gene expression in normal and fibrotic rat liver: cellular localization and regulatory factors. Hepatology 16:204-16, 1992
24. Hynes RO: Integrins: versatility modulation, and signaling in cell adhesion. Cell 69:11-25, 1992.
25. Clark EA, Brugge JS: Integrins and signal transduction pathway: the road taken. Science 268:233-9, 1995.
26. Schuppan D, Milani S: The extracellular matrix in cellular communication. In: Gressner AM, Ramadori G (eds) Molecular and cell biology of liver fibrogenesis. Boston, Dordrecht, London, Kluwer Academic Publishers, 1992, pp 52-71.
27. Miyamoto S, Akiyama SK, Yamada KM: Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science 267:883-5, 1995.
28. Schaffner F, Popper H: Capillarization of hepatic sinusoids in man. Gastroenterology 44:239-42, 1963.
29. Hahn EG, Wick G, Pencev D: Distribution of basement membrane proteins in normal and fibrotic human liver. Gut 21:63-71, 1980.
30. Milani S, Grappone C, Pellegrini G, et al: Undulin RNA and protein expression in normal and fibrotic human liver. Hepatology 20:908-16, 1994.
31. Milani S: Expression of extracellular matrix components in normal and fibrotic liver. In: Surrenti C, Casini A, Milani S, Pinzani M (eds) Fat-storing cells and liver fibrosis. Boston, Dordrecht, London, Kluwer Academic Publishers, 1994, pp 37-54.
32. Matrisian LM: Metalloproteinases and their inhibitors in matrix remodeling. Trend Genet 6:121-5, 1990.
33. Arthur MJP: Collagenases and liver fibrosis. J Hepatol 22:43-8, 1995.
34. Arthur MJP, Friedman SL, Roll FJ, et al: Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen. J Clin Invest 84:1076-85, 1989.
35. Iredale JP, Murphy G, Hembry RM, et al:. Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1: implications for regulation of matrix degradation in liver. J Clin Invest 90:282-7, 1992.
36. Kuiper J, Brouwer A, Knook DL, et al: Kupffer and sinusoidal endothelial cells. In: Arias IM, Bojer JL, Fausto N, et al (eds) The liver. Biology and pathobiology. New York, Raven Press, 1994, pp 791-818.
37. Kupffer von C: Ueber Sterzellen der leber. Briefliche Mitteilung an Prof. Waldeyer. Arck Mikr Anat 12:353-8, 1876.
38. Wake K: Perisinusoidal stellate cells (fat-storing cells, interstitial cells, lipocytes), their related structure in and around the liver sinusoids, and vitamin A-storing cells in extrahepatic organs. Int Rev Cytol 66:303-53, 1980.
39. Geerts A, De Bleser P, Hautekeete ML, et al: Fat-storing (Ito) cell biology. In: Arias IM, Bojer JL, Fausto N, et al (eds) The liver. Biology and pathobiology. New York. Raven Press, 1994, pp 819-38.
40. Pinzani M, Failli P, Ruocco C, et al: Fat-storing cells as liver-specific pericytes: spatial dynamics of agonist-stimulated intracellular calcium transients. J Clin Invest 90:642-6, 1992.
41. Kawada N, Tran-Thi T-A, Klein H, et al: The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin-1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem 213:815-23, 1993.
42. Rockey DC, Housset CN, Friedman SL: Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo. J Clin Invest 92:1795-1804, 1993.
43. Friedman SL, Roll FJ, Boyles J, et al: Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci USA 82:8681-85, 1985.
44. Milani S, Herbst H, Schuppan D, et al: In situ hybridization for procollagen types I, III and IV mRNA in normal and fibrotic rat liver: evidence for predominant expression in nonparenchymal liver cells. Hepatology 10:84-92, 1989.
45. Maher JJ, McGuire RF: Extracellular matrix gene expression increases preferentially in rat lipocyles and sinusoidal endothelial cells during hepatic fibrosis in vivo. J Clin Invest 86:1641-8, 1990.
46. Pierrangelo A, Gualdi R, Casalgrandi G, et al: Enhanced hepatic collagen type I mRNA expression into fat-storing cells in a rodent model of hemochromatosis. Hepatology 19:714-21, 1994.
47. Mak KM, Lieber CS: Lipocytes and transitional cells in alcoholic liver disease: a morphometric study. Hepatology 8:1027-33, 1988.
48. Geerts A, Lazou J-M, De Blesier P, et al: Tissue distribution, quantitation and proliferation kinetics of fat-storing cells in carbon tetrachloride-injured rat liver. Hepatology 13:1193-1202, 1991.
49. Friedman SL, Roll FJ, Boyles J, et al: Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. J Biol Chem 264:10756-62, 1989.
50. Davis BH, Pratt BM, Madri JA: Retinol and extracellular collagen matrices modulate hepatic Ito cell collagen phenotype and cellular retinol binding proteins levels. J Biol Chem 262:10280-6, 1987.
51. Ramadori G, Veit T, Schwogler S, et al: Expression of the gene of the alpha-smooth muscle-actin isoform in rat liver and in rat fat-storing (ITO) cells. Virchows Arch B Cell Pathol 59:349-57, 1990.
52. Friedman SL, Arthur MJP: Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium: direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors. J Clin Invest 84:1780-5, 1989.
53. Friedman SL, Yamasaki G, Wong L: Modulation of transforming growth factor β receptors of rat lipocytes during the hepatic wound healing response. J Biol Chem 269:10551-8, 1994.
54. Roberts AB, Anzano MA, Lamb LC: New class of transforming growth factor potentiated by epidermal growth factor. Proc Natl Acad Sci USA 78:5339-43, 1981.
55. Roberts AB, Sporn MB: The transforming growth factors betas. In: Sporn MB, Roberts AB (eds) Handbook of experimental pharmacology. Heidelberg, Springer-Verlag, 1990;95:419-72.
56. Castilla A, Prieto J, Fausto N: Transforming growth factor β1 and α in chronic liver disease. N Engl J Med 324:933-44, 1991.
57. Armendariz-Borunda J, Simkevich CP, Roy N, et al: Activation of Ito cells involves regulation of AP-1 binding proteins and induction of type I gene expression. Biochem J 304:817-24, 1994.
58. Bachem MG, Meyer D, Melchior R, et al. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. J Clin Invest 89:19-27, 1992.
59. Braun L, Mead JE, Panzica M, et al: Transforming growth factor β mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. Proc Natl Acad Sci USA 85:1539-43, 1988.
60. Kim S-J. Jeang K-T, Glick AB, et al: Promoter sequences of the human transforming growth factor β1 gene responsive to transforming growth factor β1 autoinduction. J Biol Chem 264:7041-5, 1989.
61. Ross R: Platelet-derived growth factor. Lancet i:1179-1182, 1989.
62. Heldin P, Pertoft H, Nordliner H, et al: Differential expression of platelet-derived growth factor α- and β receptors on fat-storing and endothelial cells of rat liver. Exp Cell Res 193:364-9, 1991.
63. Pinzani M, Milani S, Grappone G, et al: Expression of platelet-derived growth factor in a model of acute liver injury. Hepatology 19:701-7, 1994.
64. Wong L, Yamasaki G, Johnson RL, et al: Induction of β-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. J Clin Invest 94:1563-9, 1994.
65. Pinzani M, Gentilini A, Caligiuri A, et al: Transforming growth factor β1 regulates platelet-derived growth factor receptor β subunit in human liver fat-storing cells. Hepatology 21:232-9, 1995.
66. Marra F, Choudhury GG, Bhandari B, et al: Biology and regulation of platelet-derived growth factor. In: Surrenti C, Casini A, Milani S, Pinzani M (eds) Fat-storing cells and liver fibrosis. Boston, Dordrecht, London, Kluwer Academic Publishers, 1994, pp 209-21.
67. Williams LT: Signal transduction by the platelet-derived growth factor receptor. Science 243:1564-70, 1989.
68. Marra F, Valente AJ, Pinzani M, et al: Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. J Clin Invest 92:1674-80, 1993.
69. Pinzani M, Carloni V, Marra F, et al: Biosynthesis of platelet-activating factor and its 1-O-acyl analogue by liver fat storing cells. Gastroenterology 106:1301-11, 1994.
70. Pinzani M, Abboud HE, Gesualdo L: Regulation of macrophage-colony stimulating factor in liver fat-storing cells by peptide growth factors. Am J Physiol-Cell Physiol 262:C876-81, 1992.
71. Levene CI, Bates CJ: The effect of hypoxia on collagen synthesis in cultured 3T6 fibroblasts and its relationship to the mode of action of ascorbate. Biochim Biophys Acta 444:446-52, 1976.
72. Kirsner RS, Pardes JB, Ochoa S, et al: Oxygen tension controls collagen type I transcription. J Invest Dermatol 98:414, 1992.
73. Murrel GAC, Francis MJO, Bromley L: Modulation of fibroblast proliferation by oxygen free radicals. Biochem J 265:659-65, 1990.
74. Cadenas E: Biochemistry of oxygen toxicity. Annu Rev Biochem 58:79-110, 1989.
75. Inoue M: Protective mechanisms against reactive oxygen species. In: Arias IM, Bojer JL, Fausto N (eds) The liver. Biology and pathobiology. New York, Raven Press. 1994, pp 443-59.
76. Meier B, Radeke HH, Seller S, et al: Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumor necrosis factor-α. Biochem J 263:539-45, 1989.
77. Weiss SJ: Tissue destruction by neutrophils. N Engl J Med 320:365-76, 1989.
78. Matsubara T, Ziff M: Superoxide anion release by human endothelial cells: synergism between phorbol ester and calcium ionophore. J Cell Physiol 127:207-10, 1986.
79. de Groot H, Littauer A: Hypoxia, reactive oxygen, and cell injury. Free Rad Biol Med 6:541-51, 1989.
80. Brattin WJ, Glende EA, Recknagle RO: Pathological mechanisms in carbon tetrachloride. J Free Rad Biol Med 1:27-38, 1985.
81. Estebauer H: Cytotoxicity and genotoxicity of lipid-oxidation products. Am J Clin Nutr 57:779-86, 1993.
82. Lieber CS: Mechanism of ethanol induced hepatic injury. Pharmacol Ther 46:1-41, 1990
83. Hultcrantz R, Bissell DM, Roll FJ, et al: Iron mediates production of a neutrophill chemoattractant in rat hepatocytes metabolizing ethanol. J Clin Invest 87:45-9, 1991.
84. Lyons BL, Schwarz RI: Ascorbate stimulation of PAT cells causes an increase in transcription rates and a decrease in degradation rates of procollagen mRNA. Nucl Acids Res 12:2569-79, 1984.
85. Chojkier M, Houglum K, Solis-Herruzo JA, et al: Stimulation of collagen gene expression by ascorbic acid in cultured fibroblasts. J Biol Chem 264:16957-62, 1989.
86. Brenner DA, Chojkier M: Acetaldehyde increases collagen gene transcription in cultured human fibroblasts. J Biol Chem 262:17960-5, 1987.
87. Casini A, Cunningham M, Rojkind M, et al: Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-depen-dent mechanism. Hepatology 13:758-65, 1991.
88. Anania FA, Potter JJ, Rennietankersley L: Effects of acetaldehyde on nuclear protein binding to the nuclear factor I consensus sequence in the alpha(2)(I) collagen promoter. Hepatology 21:1640-8, 1995.
89. Parola M, Pinzani M, Casini A, et al: Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen-α1 (I) gene expression in human Ever fat-storing cells. Biochem Biophys Res Commun 194:1044-50, 1993.
90. Casini A, Ceni E, Salzano R, et al: Effect of neutrophil-derived Superoxide anion and nitric oxide on the synthesis of collagen by human fat-storing cells (FSC). J Hepatol 23:77, 1995.
91. Pietrangelo A, Gualdi R, Casalgrandi G, et al: Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents. J Clin Invest 95:1824-31, 1995.
92. Bedossa P, Houglum K, Trautwein C, et al: Stimulation of collagen alpha 1 (I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis? Hepatology 19:1262-71, 1994.
93. Pietrangelo A, Gualdi R, Montosi G, et al: Iron as a paracrine activator of liver fat-storing cells during experimental fibrosis. Hepatology 20:290A, 1994.
94. Pietrangelo A, Montosi G, Garuti C, et al: Molecular aspects of oxidative-stress associated hepatic fibrogenesis. J Hepatol 23 suppl 1:77, 1995.
95. Finch SC, Finch CA: Idiopathic hemochromatosis: an iron storage disease. Medicine 34:381-430, 1955.
96. Block M, Moore G, Wasi P, et al: Histogenesis of the hepatic lesion in primary hemochromatosis: with consideration of the pseudo iron deficient state produced by phlebotomies. Am J Pathol 47:89-123, 1965.
97. Klausner RD, Rouault TA, Harford JB: Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 72:19-28, 1993.
98. Deugnier YM, Loréal O, Turlin BD, et al: Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology 102:2050-9, 1992.
99. Stal P, Broome U, Sheynius A, et al: Kupffer cell iron overload induces intercellular adhesion molecule-1 expression on hepatocytes in genetic hemochromatosis. Hepatology 21:1308-16, 1995.
100. Gualdi R, Casalgrandi G, Montosi G, et al: Excess iron into hepatocytes is required for activation of collagen type I gene during experimental siderosis. Gastroenterology 107:1118-24, 1994.
101. Pietrangelo A, Montosi G, Garuti C, et al: Molecular and cellular aspects of liver disease in genetic hemochromatosis. Hepatology 22-1057A, 1995.
102. Goldberg L, Smith JP: Iron overloading and hepatic vulnerability. Am J Clin Pathol 25:514-542, 1955.
103. Carthew P, Edwards RE, Smith AG, et al: Rapid induction of hepatic fibrosis in the gerbil after the parenteral administration of iron-dextran complex. Hepatology 13:534-9, 1991.
104. Kent G, Volini FI, Minick OT, et al: Effect of iron loading upon the formation of collagen in the hepatic injury induced by carbon tetrachloride. Am J Pathol 45:129-55, 1964.
105. Mackinnon M, Clayton C, Plummer J, et al: Iron overload facilitates hepatic fibrosis in the rat alcohol/low-dose carbon tetra-chloride model. Hepatology 21:1083-8, 1995.
106. Tsukamoto H, Horne W, Kamimura S, et al: Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 96:620-30, 1995.
107. Iancu TC, Rabinowitz A, Brissot P, et al: Iron overload of the liver in the baboon. An ultrastructural study. J Hepatol 1:261-75, 1985.
108. Park CH, Bacon BR, Brittenham GM, et al: Pathology of dietary carbonyl iron overload in rats. Lab Invest 57:555-63, 1987.
109. Brissot P, Farjanel J, Bourel D, et al: Chronic liver iron overload in the baboon by ferric nitrilotriacetate. Morphologic and functional changes with special reference to collagen synthesis enzymes. Dig Dis Sci 32:620-7, 1987.
110. Pietrangelo A, Rocchi E, Schiaffonati L, et al: Liver gene expression during chronic dietary iron overload in rats. Hepatology 11:798-804, 1990.
111. Pietrangelo A, Quaglino D, Gualdi R, et al: Enhanced hepatic collagen gene expression in a rodent model of hemochromatosis. In: Gressner AM, Ramadori G (eds) Molecular and cell biology of liver fibrogenesis. Boston, Dordrecht, London, Kluwer Academic Publishers, 1992, pp 308-15.
112. Ramm G, Li A, Li SCY, et al: Chronic iron overload causes activation of rat lipocytes in vivo. Am J Physiol 31:G451-8, 1995.
113. Houglum K, Filip M, Witztum JL, Chojkier M: Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload. J Clin Invest 86:1991-8, 1990.
114. Pietrangelo A, Borella F, Casalgrandi G, et al: Antioxidant activity of silybin in vivo during chronic iron overload in rats. Gastroenterology 109:1941-9, 1995.
115. Pietrangelo A, Grandi R, Tripodi A, et al: Lipid composition and fluidity of liver mitochondria, microsomes and plasma membrane of rats with chronic dietary iron overload. Biochem Pharmacol 39:123-8, 1990.
116. Franklin TJ: Current approaches to the therapy of fibrotic diseases. Biochem Pharmacol 49:267-73, 1995.
117. Brenner DA, Westwick J, Breindl M: Type I collagen gene regulation and the molecular pathogenesis of cirrhosis.Am J Physiol 264:6589-95.